Zobrazeno 1 - 10
of 193
pro vyhledávání: '"S. Thezenas"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Jean-Yves Blay, Charles Honoré, Marick Laé, Audrey Monneur, Mehdi Brahmi, Fabien Reyal, Nicolas Isambert, Camille Chakiba, Esma Saada-Bouzid, Sophie Piperno-Neumann, Thomas Ryckewaert, Nelly Firmin, S. Thezenas, Christophe Sajous, Nicolas Penel, Sébastien Salas, Mathias Neron, Isabelle Ray-Coquard, François Bertucci, Florence Duffaud
Publikováno v:
Annals of Surgical Oncology
Annals of Surgical Oncology, Springer Verlag, 2019, ⟨10.1245/s10434-019-08097-x⟩
Annals of Surgical Oncology, 2019, ⟨10.1245/s10434-019-08097-x⟩
Annals of Surgical Oncology, Springer Verlag, 2019, ⟨10.1245/s10434-019-08097-x⟩
Annals of Surgical Oncology, 2019, ⟨10.1245/s10434-019-08097-x⟩
Metastatic phyllodes tumors have poor prognosis with median overall survival of 11.5 months. The objective of this study is to identify prognostic factors and the best options for management of metastatic malignant phyllode tumors (MMPTs). A multicen
Autor:
Vickie E. Baracos, Chloé Janiszewski, Bruno Raynard, S. Thezenas, Estelle Guerdoux-Ninot, N. Flori, Hélène de Forges, Arnaud Vaillé, Pierre Senesse
Publikováno v:
Clinical Nutrition
Clinical Nutrition, Elsevier, 2019, 38, pp.1927-1935. ⟨10.1016/j.clnu.2018.06.974⟩
Clinical Nutrition, Elsevier, 2019, 38, pp.1927-1935. ⟨10.1016/j.clnu.2018.06.974⟩
Summary Background & aims Energy intake and food ingesta are central in nutritional screening and assessment. Cancer patients are at nutritional risk of losing weight, and clinicians need quick and easy tools to identify patients for nutritional supp
Autor:
Jean-Yves Blay, Sophie Piperno-Neumann, Mehdi Brahmi, Fabien Reyal, Marick Laé, Clémentine Owen, Nicolas Penel, Sébastien Salas, Thibaud Valentin, S. Thezenas, Emmanuelle Bompas, Camille Chakiba, Charles Honoré, Isabelle Ray-Coquard, A. Michot, Nelly Firmin, Mathias Neron, Esma Saada-Bouzid, Christophe Sajous, François Bertucci
Publikováno v:
Annals of Surgical Oncology
Annals of Surgical Oncology, 2020, 27 (6), pp.1818-1827. ⟨10.1245/s10434-020-08217-y⟩
Annals of Surgical Oncology, 2020, 27 (6), pp.1818-1827. ⟨10.1245/s10434-020-08217-y⟩
The optimal threshold of surgical margins for breast malignant phyllodes tumors (MPTs) and the impact of adjuvant chemotherapy and radiotherapy were investigated.We conducted a multicenter nationwide retrospective study of all MPT cases with central
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e897661b54fa8991b78799f6239213d
https://amu.hal.science/hal-03623684
https://amu.hal.science/hal-03623684
Autor:
Pierre-Emmanuel Colombo, C. Lemanski, Laure Delmond, Aurélie Morel, D. Azria, Marian Gutowski, A. Mourregot, Philippe Rouanet, S. Thezenas, N. Aillères, Céline Bourgier, Roxanna Draghici, Pascal Fenoglietto
Publikováno v:
Cancer Radiothérapie
Cancer Radiothérapie, Elsevier Masson, 2020, 24, pp.114-119. ⟨10.1016/j.canrad.2020.01.007⟩
Cancer Radiothérapie, Elsevier Masson, 2020, 24, pp.114-119. ⟨10.1016/j.canrad.2020.01.007⟩
To evaluate our long-term experience on one-day breast intraoperative radiotherapy (IORT) given as sole radiation treatment to selected patients with breast cancer.Inclusion criteria of INTRAOBS study (prospective observational study) were: ER+ T1N0
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36c24f99f54fee1479d340a5eae6e291
https://hal.archives-ouvertes.fr/hal-03490344
https://hal.archives-ouvertes.fr/hal-03490344
Autor:
Pascal Fenoglietto, C. Llacer-Moscardo, Charles Debrigode, David Azria, Thibault Mazard, S. Vieillot, Sophie Gourgou, Emmanuelle Samalin, Mailys de Meric de Bellefon, Sylvain Demontoy, Olivier Riou, N. Aillères, Alexis Lenglet, Claire Lemanski, Florence Castan, S. Thezenas
Publikováno v:
Radiotherapy and Oncology
Radiotherapy and Oncology, Elsevier, 2020, 144, pp.141-147. ⟨10.1016/j.radonc.2019.11.016⟩
Radiotherapy & Oncology
Radiotherapy & Oncology, Elsevier, 2020, 144, pp.141-147. ⟨10.1016/j.radonc.2019.11.016⟩
Radiotherapy and Oncology, Elsevier, 2020, 144, pp.141-147. ⟨10.1016/j.radonc.2019.11.016⟩
Radiotherapy & Oncology
Radiotherapy & Oncology, Elsevier, 2020, 144, pp.141-147. ⟨10.1016/j.radonc.2019.11.016⟩
International audience; Background and purpose: To assess the long-term outcomes of patients with squamous cell carcinoma of the anal canal (SCCAC) treated with Intensity-Modulated Radiation Therapy (IMRT).Material and methods: From 2007 to 2015, 193
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e24ec7818bd529a1cb7c64d5c1aeb1e
https://hal.archives-ouvertes.fr/hal-03488620
https://hal.archives-ouvertes.fr/hal-03488620
Autor:
Alexandra Thomas, Sarah L. Mott, Marie Viala, William Jacot, Laure Delmond, S. Thezenas, Mary C. Schroeder, Akiko Chiba, P-J Lamy
Publikováno v:
Cancer Research. 78:P2-10
Introduction: There has been increasing interest in the potential benefit of vitamin D to improve breast cancer outcomes. Pre-clinical studies suggest vitamin D enhances chemotherapy-induced cell death. We previously reported (Thomas A SABCS 2016) th
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
The American Journal of Clinical Nutrition
The American Journal of Clinical Nutrition, Oxford University Press, 2021, 113 (4), pp.1054-1055. ⟨10.1093/ajcn/nqaa425⟩
The American Journal of Clinical Nutrition, Oxford University Press, 2021, 113 (4), pp.1054-1055. ⟨10.1093/ajcn/nqaa425⟩
International audience; A double-blind phase III trial of immunomodulating nutritional formula during adjuvant chemoradiotherapy in head and neck cancer patients: IMPATOX. Boisselier P, Kaminsky MC, Thézenas S, Gallocher O, Lavau-Denes S, Garcia-Ram
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.